Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionPerpetual Ltd
Latest Disclosed Ownership18,083 shares
Latest Disclosed Value $ 2,520,227
Perpetual Ltd reports 36.55% decrease in ownership of GILD / Gilead Sciences, Inc.

On April 14, 2026 - Perpetual Ltd filed a 13F-HR form disclosing ownership of 18,083 shares of Gilead Sciences, Inc. (CH:GILD) valued at $2,520,227 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 28,498 shares of Gilead Sciences, Inc.. This represents a change in shares of -36.55% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-14 2026-03-31 13F GILEAD SCIENCES COM 375558103 18,083 -10,415 -36.55 2,520 -27.94 0.0387
2026-01-20 2025-12-31 13F GILEAD SCIENCES COM 375558103 28,498 15,422 117.94 3,498 141.01 0.0506
2025-10-10 2025-09-30 13F GILEAD SCIENCES COM 375558103 13,076 915 7.52 1,451 7.64 0.0180
2025-07-11 2025-06-30 13F GILEAD SCIENCES COM 375558103 12,161 -2,478 -16.93 1,348 -17.80 0.0158
2025-04-24 2025-03-31 13F GILEAD SCIENCES COM 375558103 14,639 -1,515 -9.38 1,640 9.92 0.0198
2025-01-17 2024-12-31 13F GILEAD SCIENCES COM 375558103 16,154 0 0.00 1,492 10.19 0.0175
2024-10-09 2024-09-30 13F GILEAD SCIENCES COM 375558103 16,154 0 0.00 1,354 22.20 0.0147
2024-07-30 2024-06-30 13F GILEAD SCIENCES COM 375558103 16,154 2,260 16.27 1,108 8.95 0.0120
2024-04-16 2024-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 13,894 11 0.08 1,018 -9.52 0.0099
2024-04-10 2024-03-31 13F GILEAD SCIENCES COM 375558103 13,894 11 1,018 0.0063
2024-02-15 2023-12-31 13F GILEAD SCIENCES COM 375558103 13,883 -30,026 -68.38 1,125 -65.84 0.0116
2023-10-10 2023-09-30 13F GILEAD SCIENCES COM 375558103 43,909 -3,935 -8.22 3,291 -10.77 0.0340
2023-07-13 2023-06-30 13F GILEAD SCIENCES COM 375558103 47,844 -5,555 -10.40 3,687 -16.77 0.0316
2023-05-08 2023-03-31 13F GILEAD SCIENCES COM 375558103 53,399 38,062 248.17 4,431 357.17 0.0383
2020-12-08 2020-09-30 13F GILEAD SCIENCES COM 375558103 15,337 937 6.51 969 -12.55 0.0697
2020-12-08 2020-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 14,400 14,400 1,108 0.1036
2020-11-18 2020-06-30 13F GILEAD SCIENCES COM 375558103 14,400 14,400 2,337 102,810.3248
2020-12-08 2020-03-31 13F/A-1 Gilead Sciences COM 375558103 0 -14,400 -100.00 0 -100.00
2020-02-12 2019-12-31 13F Gilead Sciences COM 375558103 14,400 0 0.00 934 2.30 0.1387
2019-10-10 2019-09-30 13F Gilead Sciences COM 375558103 14,400 0 0.00 913 -6.17 0.1405
2019-07-30 2019-06-30 13F Gilead Sciences COM 375558103 14,400 -2,100 -12.73 973 -9.32 0.1549
2019-05-06 2019-03-31 13F GILEAD SCIENCES COM 375558103 16,500 0 0.00 1,073 5.09 0.1552
2019-02-08 2018-12-31 13F GILEAD SCIENCES COM 375558103 16,500 0 0.00 1,021 -19.86 0.1533
2018-10-30 2018-09-30 13F GILEAD SCIENCES COM 375558103 16,500 0 0.00 1,274 8.80 0.1712
2018-07-23 2018-06-30 13F GILEAD SCIENCES COM 375558103 16,500 2,000 13.79 1,171 7.14 0.1425
2018-04-18 2018-03-31 13F GILEAD SCIENCES COM 375558103 14,500 0 0.00 1,093 3.80 0.1489
2018-02-12 2017-12-31 13F GILEAD SCIENCES COM 375558103 14,500 700 5.07 1,053 -8.12 0.1361
2017-11-01 2017-09-30 13F GILEAD SCIENCES COM 375558103 13,800 -162,100 -92.15 1,146 -90.80 0.1599
2017-09-26 2017-06-30 13F GILEAD SCIENCES COM 375558103 175,900 16,100 10.08 12,450 17.19 0.9731
2017-09-26 2017-03-31 13F GILEAD SCIENCES COM 375558103 159,800 150,400 1,600.00 10,624 1,327.96 1.0550
2017-09-26 2016-09-30 13F GILEAD SCIENCES COM 375558103 9,400 -14,400 -60.50 744 -62.52 0.0610
2017-09-26 2016-06-30 13F GILEAD SCIENCES COM 375558103 23,800 3,800 19.00 1,985 8.06 0.1974
2017-09-26 2016-03-31 13F GILEAD SCIENCES COM 375558103 20,000 3,800 23.46 1,837 12.08 0.1863
2017-09-26 2015-12-31 13F GILEAD SCIENCES COM 375558103 16,200 2,200 15.71 1,639 19.20 0.1831
2017-09-26 2015-09-30 13F GILEAD SCIENCES COM 375558103 14,000 -700 -4.76 1,375 -20.10 0.1634
2017-09-26 2015-06-30 13F GILEAD SCIENCES COM 375558103 14,700 14,700 1,721 0.1975
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.